USPTO trademark

LONGAVO

AllowedUSPTOWord markClass 5

"LONGAVO" is a word mark owned by Teva Pharmaceuticals USA, Inc., filed at the USPTO on June 14, 2023. It has been allowed and covers class 5 (Pharmaceuticals).

View Teva Pharmaceuticals USA, Inc. portfolioGet this data via the API
Official USPTO record
LONGAVO trademark as filed
As filed with the USPTO
Status
Allowed
Since October 19, 2026
Filed
June 14, 2023
Registered
Not yet
Expires
Not recorded
Application no.
98041822
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns LONGAVO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Teva Pharmaceuticals USA, Inc.

Parsippany, United States

648 trademarks in the portfolioView company

Representative

Lori Wolfe

Teva Pharmaceuticals USA, Inc.

Goods and services

What the mark covers

The products and services LONGAVO is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 5 granted
  3. Sou extension 5 filed
  4. Sou teas extension received
  5. Notice of approval of extension request e-mailed
  6. Sou extension 4 granted
  7. Case assigned to intent to use paralegal
  8. Sou extension received with teas petition
  9. Notice of revival - e-mailed
  10. Petition to revive-granted

10 earlier steps on the official record.

FAQ

About LONGAVO

Who owns the trademark "LONGAVO"?

The USPTO trademark "LONGAVO" (application 98041822) is owned by Teva Pharmaceuticals USA, Inc.

What is the status of "LONGAVO"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LONGAVO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2bd1-1af2-72eb-90d9-995707f88911
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bd1-1af2-72eb-90d9-995707f88911",
  "object": "trademark",
  "mark_text": "LONGAVO",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "98041822",
  "filing_date": "2023-06-14",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "TEVA PHARMACEUTICALS USA, Inc.",
      "entity_id": "ent_019fc41c-ecc5-76e9-863d-e500c53224ec"
    }
  ]
}